@article{JTD25349,
author = {Yukinori Matsuo},
title = {Sarcopenia is a potential factor for optimized treatment selection for elderly patients with early stage non-small cell lung cancer},
journal = {Journal of Thoracic Disease},
volume = {11},
number = {Suppl 3},
year = {2018},
keywords = {},
abstract = {Sarcopenia is a syndrome characterized by progressive and generalized loss of skeletal muscle mass (SMM) and strength with a risk of adverse outcomes such as physical disability, poor quality of life, and death by the European Working Group on Sarcopenia in Older People (EWGSOP) (1).},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/25349}
}